What we are studying
The purpose of this study is to compare the combination of carboplatin, paclitaxel and veliparib to carboplatin, paclitaxel, and placebo followed by continued therapy with either veliparib or placebo to determine if it slows the progression of your cancer. A BRCA gene test will be required for your participation to further assess treatment response. You will need to have this sample collected, even if you have already been tested for it previously.
Parking will be validated for study-related visits